GSK, Thalidomide Plaintiffs Spar Over Pa., Federal Jurisdiction
Two people born with birth defects allegedly caused by the morning-sickness drug thalidomide squared off with GlaxoSmithKline PLC in front of the Third Circuit Tuesday, with the plaintiffs arguing that their...To view the full article, register now.
Already a subscriber? Click here to view full article